Navigoe Wealth Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$135K Buy
113
+9
+9% +$9.2K 0.07% 56
2026
Q1
$95K Sell
104
-30
-22% -$30.4K 0.06% 61
2025
Q4
$144K Hold
134
– – 0.09% 47
2025
Q3
$102K Buy
134
+33
+33% +$24.6K 0.07% 59
2025
Q2
$78K Hold
101
– – 0.06% 58
2025
Q1
$83K Hold
101
– – 0.07% 53
2024
Q4
$77K Buy
+101
New +$83.6K 0.08% 52

Other funds holding LLY

Navigoe Wealth Management's LLY Position: Q2 2026 in Review

Navigoe Wealth Management increased its Eli Lilly (LLY) stake by 8.7% in Q2 2026, buying an estimated $9.2K and bringing the position to 113 shares worth $135K. The position accounts for 0.07% of the portfolio, ranked #56.

Navigoe Wealth Management first reported a position in LLY in Q4 2024 and has held it in 7 quarters since. The position peaked at $144K in Q4 2025. 4,642 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Navigoe Wealth Management held 113 shares of Eli Lilly worth $135K as of Q2 2026.
  • Navigoe Wealth Management bought 9 Eli Lilly shares in Q2 2026, an estimated $9.2K.
  • Eli Lilly made up 0.07% of Navigoe Wealth Management's portfolio in Q2 2026, its #56 holding.
  • Navigoe Wealth Management first reported a position in Eli Lilly in Q4 2024 and has held it in 7 quarters since.
  • Navigoe Wealth Management's Eli Lilly position peaked at $144K in Q4 2025.
  • 4,642 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Navigoe Wealth Management's 13F filing for Q2 2026, filed 31 Jul 2026.